COLL - Collegium enters authorized generic agreement with Hikma for Nucynta franchise
2024-04-29 10:13:02 ET
More on Collegium Pharmaceutical
- Collegium Pharmaceutical Q4: The Beat Goes On
- Collegium Pharmaceutical's (COLL) Q4 2023 Earnings Call Transcript
- Collegium Pharmaceutical, Inc. 2023 Q4 - Results - Earnings Call Presentation
- Collegium Pharmaceutical to redeem outstanding 2.625% convertible senior notes due 2026
- Collegium Pharmaceutical Q4 2023 Earnings Preview